Reviews

TCM medicine understanding of tumor microenvironment based on cancer toxicity theory

  • Danting WEN ,
  • Huiping. ZHOU
Expand
  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China

Received date: 2023-07-14

  Online published: 2023-11-22

Abstract

As a tumor ecosystem on which tumors grow and develop, tumor microenvironment is the key to tumor occurrence and development. In terms of cancer toxicity theory, the formation and transformation of tumor microenvironment are closely related to different stages of cancer toxicity development. The treatment of tumor microenvironment can be carried out according to the pathological characteristics of different stages of cancer development. Based on the theory of cancer toxicity, this paper explores the TCM understanding of tumor microenvironment by finding out the commonality of development characteristics between cancer toxicity and tumor microenvironment, and provides theoretical basis for TCM treatment of tumor microenvironment.

Cite this article

Danting WEN , Huiping. ZHOU . TCM medicine understanding of tumor microenvironment based on cancer toxicity theory[J]. The Journal of Practical Medicine, 2023 , 39(19) : 2556 -2560 . DOI: 10.3969/j.issn.1006-5725.2023.19.025

References

1 SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin,2021, 71(3): 209-249.
2 JONASCH E, ATKINS M B, CHOWDHURY S, et al. Combination of anti-angiogenics and checkpoint inhibitors for renal cell ccarcinoma: is the whole greater than the sum of its parts? [J]. Cancers (Basel), 2022, 14(3): 644.
3 程海波,吴勉华.周仲瑛教授“癌毒”学术思想探析[J].中华中医药杂志,2010,25(6):866-869.
4 PAGET S. The distribution of secondary growths in cancer of the breast [J]. The Lancet, 1889, 133(3421): 571-573.
5 CHEN Q, ZHANG M, HUANG H, et al. Single atom-doped nanosonosensitizers for mutually optimized sono/chemo-nanodynamic therapy of triple negative breast cancer [J]. Adv Sci (Weinh), 2023, 10(6): e2206244.
6 蒲雨康,黄玉琴,李伟 等.基于生物学信息探讨KIF26B在上皮性卵巢癌中的表达及临床意义[J].实用医学杂志,2022,38(23):2919-2926.
7 唐幸林子,王志宇,王能.基于癌毒病机理论探讨外泌体对肿瘤及肿瘤微环境的交互作用[J].中华中医药杂志,2021,36(11):6770-6774.
8 KHATAMI M. ‘Yin and Yang’ in inflammation: duality in innate immune cell function and tumorigenesis [J]. Expert Opin Biol Ther, 2008, 8(10): 1461-1472.
9 潘磊,夏孟蛟,李蒙丽,等.营卫不和与肿瘤的发生发展[J].中华中医药杂志,2019,34(1):47-49.
10 于鹏龙,张宏方,于东波,等. 试论肿瘤微环境对中医“癌毒”学说的认知意义[J]. 现代中医药,2016,36(1):47-49.
11 郭建辉. 周仲瑛教授“癌毒学说”新论[J]. 湖南中医药大学学报,2010,30(11):6-8.
12 黄帝内经素问[M]. 北京:人民卫生出版社,2012:53,95,391.
13 余听鸿. 外证医案汇编[M]. 上海:上海科学技术出版社,2010:162.
14 王冰冰,高永翔. 免疫学理论与中医学理论的相关性[J]. 四川中医,2015,33(2):34-36.
15 刘莹莹,张国尊,梁育飞,等. 益脾养肝法联合TACE对原发性肝癌患者肝功能及巨噬细胞介导细胞因子水平的影响[J]. 湖北中医药大学学报,2022,24(5):39-42.
16 王梅,武英茹,王越欣,等. 不同米炒党参对脾虚大鼠胃肠道功能、免疫功能、水液代谢的影响[J]. 中药材,2021,44(11):2566-2570.
17 CAO S, HUNG Y W, WANG Y C, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors [J]. Theranostics, 2022, 12(13): 6038-6056.
18 HASSAN G, OHARA T, AFIFY S M, et al. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways [J]. J Exp Clin Cancer Res, 2022, 41(1): 29.
19 SCHNEIDER K M, MOHS A, GUI W, et al. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment [J]. Nat Commun, 2022, 13(1): 3964.
20 MEDZHITOV R. Origin and physiological roles of inflammation [J]. Nature, 2008, 454(7203): 428-435.
21 梁桂林,罗毅,王彬,等. 固本宣肺汤治疗稳定期慢性阻塞性肺疾病疗效及对免疫功能的影响[J]. 中华中医药学刊,2020,38(8): 183-186.
22 翟春艳,底婷婷,王燕,等. 健脾养血解毒方通过调节Treg/Th17免疫平衡改善脾虚-银屑病复合模型小鼠银屑病样皮损[J]. 中华中医药学刊,2019,37(12):2888-2893+3103-3106.
23 于勇,黄雅慧,赵唯含,等. 益气活血法对慢性萎缩性胃炎癌前病变Ki-67和肿瘤标记物的影响[J]. 广州中医药大学学报,2023,40(2):329-335.
24 龚廷贤. 寿世保元[M]. 王均宁,点校.天津:天津科学技术出版社,1999:147.
25 ULLRICH M, RICHTER S, LIERS J, et al. Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models [J]. Theranostics, 2023, 13(1): 278-294.
26 HSU K W, LAI J C, CHANG J S, et al. METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets [J]. Genome Biol, 2022, 23(1): 249.
27 GAN L, LI Q, NIE W, et al. PROX1-mediated epigenetic silencing of SIRT3 contributes to proliferation and glucose metabolism in colorectal cancer [J]. Int J Biol Sci, 2023, 19(1): 50-65.
28 刘杰. 健脾化痰祛湿方对非小细胞肺癌患者的临床疗效及血清EGFR、Akt和MMP-9水平的影响[J]. 四川中医,2023,41(1):88-91.
29 王勇,孙林科. 基于网络药理学探析化痰消瘀方治疗食管癌的机制[J]. 中医临床研究,2022,14(25):35-38.
30 谭宝,石海莲,季光,等. 蒲公英萜醇和乙酰蒲公英萜醇对胃癌细胞株AGS细胞周期和凋亡的影响[J]. 中西医结合学报,2011,9(6):638-642.
31 李礼斌,魏旻俊,李洪玉,等. 浙江与广西产三叶青水煎液体内肺癌抑制作用的对比研究[J]. 中国中医药科技,2021,28(5):730-733.
32 沈克平,刘威,胡兵,等. 四藤方对人胃癌SGC-7901细胞黏附和侵袭的影响[J]. 世界华人消化杂志,2010,18(34):3616-3620.
33 张健,王沛. 中医传舍理论与肿瘤转移[J]. 中国中医基础医学杂志,1999, 5(6):4-6.
34 王笑民,张青. 基于"癌毒"的肿瘤发生发展规律探讨[J]. 中华中医药杂志, 2011,26(7):1533-1536.
35 KOBAYASHI M, WADA H, FUKUI S, et al. A Clot Waveform analysis showing a hypercoagulable state in patients with malignant neoplasms [J]. J Clin Med, 2021, 10(22): 5352.
36 CARMELIET P, JAIN R K. Angiogenesis in cancer and other diseases [J]. Nature, 2000, 407(6801) :249-257.
37 ZENG L, WU Q, WANG T, et al. Selective stabilization of multiple promoter G-quadruplex DNA by using 2-phenyl-1H-imidazole-based tanshinone IIA derivatives and their potential suppressing function in the metastatic breast cancer [J]. Bioorg Chem, 2021, 106:104433.
38 铁明慧,张颖,王科. 鳖甲煎丸对肝癌皮下转移瘤小鼠肿瘤新生血管及微环境的影响[J]. 中医杂志,2018,59(4):325-328.
39 王征,耿平,左丽,等. 肿瘤化疗患者P-选择素、TF状态及川芎嗪对其影响的临床研究[J]. 辽宁中医杂志,2014,41(5):912-914.
40 李克雄,曾普华,郜文辉,等. 基于“癌毒致虚”理论探讨肿瘤恶病质的中医药治疗[J]. 亚太传统医药,2019,15(10):90-92.
41 SCHINK K, HERRMANN H J, SCHWAPPACHER R, et al. Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial [J]. BMC Cancer, 2018, 18(1): 886.
42 HENRIQUES F S, SERTIé R A L, FRANCO F O, et al. Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome [J]. FASEB J, 2017, 31(5): 1976-1986.
43 JENSEN K S, BINDERUP T, JENSEN K T, et al. FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function [J]. EMBO J, 2011, 30(22): 4554-4570.
44 王钰,武玉,王琪格,等. 探讨脾与线粒体科学内涵的中医文献评析[J]. 时珍国医国药,2019,30(6):1535-1538.
45 刘友章,王昌俊,周俊亮,等. 长期脾虚模型大鼠细胞线粒体的研究[J]. 中医药学刊,2006,24(3):391-394.
46 冀楠,王俊岩,宋囡,等. 健脾祛痰化瘀方药对脾虚痰浊巴马小型猪回肠线粒体能量代谢相关基因干预作用研究[J]. 中华中医药学刊,2017,35(9):2349-2351.
47 刘娜,孟令占,刘勇,等. 温肾健脾法治疗晚期肿瘤恶病质的临床研究[J]. 陕西中医,2015,36(6):684-686.
48 周丽,郭勇. 益气养阴中药改善小鼠模型癌性恶病质实验研究[J]. 实用中医药杂志,2012,28(4):264-266.
Outlines

/